Smart MDR offers an exclusive campaign for startups looking to market their medical devices in the European market!

Smart MDR, a specialist in consulting for medical devices and in vitro diagnostic devices, is offering a unique opportunity to support startups and SMEs in expanding into the European market with complete and simplified regulatory support.

What's included in the campaign:

  • 10% discount on the complete CE marking process: an essential step to ensure your medical devices comply with European Union regulations.

  • 6 months of free PRRC (Person Responsible for Regulatory Compliance) services: a requirement under the European Medical Devices Regulation 2017/745, ensuring companies have a qualified professional to guarantee compliance with the required standards. This offer is an excellent opportunity for startups that do not yet have a PRRC on their team, allowing them to meet this legal obligation without additional costs for the first six months.

How to get started?

Schedule a meeting with us, and during the conversation, we will get to know your device, understand the challenges you face, and present the best way to help your company succeed in the European market with confidence and compliance.

This campaign offers a unique opportunity for companies looking to advance with specialized regulatory support and take advantage of a dedicated PRRC with reduced costs. Many startups struggle to find competent professionals with the qualifications required by the MDR. With Smart MDR, you ensure your device's compliance while receiving support from a highly qualified PRRC, without the need to hire a new team member.

Our team of experts, including Sandra Balseiro, a consultant with over 20 years of experience in medical device regulation, is ready to guide your company through each step of the process. We are here to help you navigate the complexities of regulatory compliance and ensure that your medical devices, IVD, or SaMD are market-ready.

Don’t miss this unique opportunity! Schedule your meeting now and start your journey to success in the European market. This offer is available only until January 31st.

Anterior
Anterior

FDA Issues Comprehensive Guidance on the Use of AI Models for Regulatory Decision-Making in Drug Development

Próximo
Próximo

Second Draft of General-Purpose AI Code of Practice Published